» Articles » PMID: 12502699

Decreased Glucagon-like Peptide 1 Fasting Levels in Type 2 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2002 Dec 28
PMID 12502699
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Gut-Centric Model of Metabolic Homeostasis.

Rajagopalan H, Lopez-Talavera J, Klonoff D, Cherrington A J Diabetes Sci Technol. 2021; 16(6):1567-1574.

PMID: 34697950 PMC: 9631542. DOI: 10.1177/19322968211044523.


Analysis of patient-specific factors contributing to effectiveness of glucagon-like peptide-1 receptor agonists.

Mazzei K, Trippett A, Hedrick T, Wen S J Am Pharm Assoc (2003). 2020; 60(6):937-942.

PMID: 32778515 PMC: 8358935. DOI: 10.1016/j.japh.2020.06.023.


GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats.

Lee S, Kuo F, Cheng J, Wu M Diabetes Metab Syndr Obes. 2019; 12:873-881.

PMID: 31354323 PMC: 6580122. DOI: 10.2147/DMSO.S207596.


Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus.

Yoo S, Yang E, Koh G Diabetes Metab J. 2019; 43(4):495-503.

PMID: 30877705 PMC: 6712231. DOI: 10.4093/dmj.2018.0105.


Accumulation of intestinal tissue 3-deoxyglucosone attenuated GLP-1 secretion and its insulinotropic effect in rats.

Zhang L, Song X, Zhou L, Liang G, Xu H, Wang F Diabetol Metab Syndr. 2016; 8:78.

PMID: 27956941 PMC: 5129672. DOI: 10.1186/s13098-016-0194-9.